Delivery Order SPE2DB24D2205-SPE2DB24FDYSC
Award Date
8/16/24
Potential Completion Date
8/19/24
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $17,653.46 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of GARDASIL 9 SYRINGE 0.5ML. This contract has an ultimate completion date of March 10, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the supply of GARDASIL 9 syringes (0.5 mL) to the Defense Logistics Agency (DLA) Troop Support Medical. The $10,321.87 firm fixed-price delivery order has an ultimate completion date of October 9, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a range of medical...
The Defense Logistics Agency (DLA) awarded a $11,964.24 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GARDASIL 9 SYRINGE 0.5ML. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office Division. The $3,233.58 firm-fixed-price delivery order is for the supply of 4,565,699 units of the GARDASIL 9 vaccine syringe (0.5mL) with no set-aside designation. The contract has an ultimate completion date of September 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and...
The U.S. Defense Logistics Agency (DLA) awarded a $8,720.22 firm-fixed price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of GARDASIL 9 SYRINGE 0.5ML vaccines. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a $8,427.25 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the delivery of 4,565,296,692 units of the GARDASIL 9 vaccine syringe (0.5mL) to support federal healthcare programs. The contract has an ultimate completion date of July 31, 2024 and was awarded on July 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds multiple Indefinite Delivery...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide GARDASIL 9 SYRINGE 0.5ML. This $11,765.66 delivery order contract has an ultimate completion date of April 3, 2024. AmerisourceBergen Drug Corp serves as the prime contractor on this contract, which is not set aside for any specific business type. This delivery order is part of a larger indefinite delivery contract (IDC)...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,233.58 firm fixed price delivery order contract (SPE2DX15D3008|SPE2DX24F11HV) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of GARDASIL 9 SYRINGE 0.5ML. This delivery order is part of a broader indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver pharmaceutical products and medical supplies...
The U.S. Defense Logistics Agency (DLA) awarded a $32,103.85 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 4,565,218,430 units of the GARDASIL 9 vaccine syringe (0.5 mL). This delivery order falls under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025. The contract has no set-aside designation and is for the delivery of critical...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of GARDASIL 9 syringes. This $37,681.42 Firm Fixed Price contract has a completion date of December 10, 2024. The award is not associated with a set-aside program. AmerisourceBergen, the prime contractor, has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which...